NONSMALL CELL LUNG CANCER
Clinical trials for NONSMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new NONSMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for NONSMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Radioactive 'Smart Bomb' targets Hard-to-Treat cancers in first human test
Disease control Recruiting nowThis early-stage trial tests a new drug called 212Pb-DOTAM-GRPR1, which delivers a tiny dose of radiation directly to cancer cells that have a specific marker (GRPR). The study will include 48 adults with advanced cancers such as prostate, breast, lung, colon, cervical, or brain …
Matched conditions: NONSMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Orano Med Theranostics, SAS • Aim: Disease control
Last updated Jun 22, 2026 11:59 UTC
-
New hope for lung cancer: first human trial of targeted drug DZD6008 begins
Disease control Recruiting nowThis study tests a new drug called DZD6008 in people with advanced non-small cell lung cancer that has a specific EGFR mutation. It is the first time this drug is being given to humans, so the main goals are to check its safety and find the right dose. About 190 adults will take …
Matched conditions: NONSMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Dizal Pharmaceuticals • Aim: Disease control
Last updated Jun 18, 2026 11:47 UTC
-
New study aims to extend lifesaving lung cancer treatment to weaker patients
Disease control Recruiting nowThis study looks at whether people with advanced non-small cell lung cancer who are in poorer health (Performance Status 2) can benefit from the same chemo/immunotherapy as healthier patients. The goal is to see if the treatment works just as well and is safe for them. About 105 …
Matched conditions: NONSMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 10, 2026 13:26 UTC
-
New program aims to ease distress for advanced lung cancer patients
Symptom relief Recruiting nowThis study is testing a new program called POISE for people with stage IV non-small cell lung cancer who are on targeted therapy. The program includes four visits with a specially trained palliative care clinician to help patients cope with uncertainty and manage their cancer. Re…
Matched conditions: NONSMALL CELL LUNG CANCER
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 17, 2026 12:04 UTC
-
AI takes on lung cancer: can a computer match a Doctor's wisdom?
Knowledge-focused Recruiting nowThis study tests whether an artificial intelligence (AI) model can help doctors make better treatment decisions for non-small cell lung cancer (NSCLC). About 300 patients will have their treatment plans created by both a standard team of doctors and the AI. Researchers will compa…
Matched conditions: NONSMALL CELL LUNG CANCER
Phase: NA • Sponsor: Wen-zhao ZHONG • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:54 UTC